Skip to main content

M. Patricia Rivera, MD

Professor of Medicine, Division of Pulmonary Diseases and Critical Care Medicine
Medical Director, PFT and Bronchoscopy Services
Service Chief, Pulmonary Inpatient Service

Specialty Areas: Care of patients with lung cancer, immunocompromised hosts, lung screen screening, novel approaches for early detection of lung cancer in high-risk patients, chemotherapy and radiation-induced pneumonitis

Chronology: BS Summa cum laude:(1981) Pace University (1981); MD: State University of NY at Stony Brook (1985); Internship and Residency: North Shore University Hospital (1985-1988); Fellowship: Pulmonary Medicine; Memorial Sloan-Kettering Cancer Center (1988-1989; 1990-1992); Chief Resident, Internal Medicine Memorial Sloan-Kettering Cancer Center (1989-1990)

Dr. Rivera is a Professor of Medicine in the Division of Pulmonary Diseases and Critical Care Medicine at the University of North Carolina (UNC) at Chapel Hill. She joined the faculty at UNC in 1995 and co-founded the first Multidisciplinary Thoracic Oncology Program in the country, a premier program that became the model for multidisciplinary care and defined the vital role pulmonologists play in the care of patients with thoracic malignancies. More recently, she founded the Multidisciplinary Lung Cancer Screening Program at UNC and continues to direct both programs. Her expertise includes screening, diagnosis and staging of lung cancer and management of treatment complications.

Dr. Rivera holds several vital leadership roles at UNC and for more than 20 years has served national pulmonary and cancer societies including the American Thoracic Society (ATS, The American College of Chest Physicians (CHEST) and the American Cancer Society National Lung Cancer Round Table through numerous leadership roles and by sharing her time, knowledge and passion to advance the field of Thoracic Oncology

Dr. Rivera collaborates with colleagues at UNC on NIH/NCI funded research and has co-developed and serves as Co-Investigator of the North Carolina (NC) Lung Screening Registry, a statewide initiative to examine the delivery, quality and outcomes of lung cancer screening and evaluate the extent to which disparities in lung cancer screening outcomes exist. Her ongoing funded research activities also include a multi-institution pilot project exploring presence of coronary artery calcification on lung cancer screening CT and downstream risk stratification and statin delivery and exploring rural/urban disparities associated with biomarker testing in advanced lung cancer.

Dr. Rivera is passionate and committed to medical education and mentoring and has received numerous awards at UNC and from National Societies. She is particularly passionate about developing the next generation of leaders and increasing the representation of women and underrepresented minorities in our field.

Notable Honors and Awards:

  1. Member of the ABIM Pulmonary Exam Committee 2019-
  2. 2019 Assembly on Thoracic Oncology Lifetime Achievement Award.
  3. Latin Medical Student Association Inaugural CHARLA Lecture 2019
  4. The First Annual Pulmonary and Critical Care Division Faculty Teacher of the Year Award 2018
  5. CHEST Presidential Honor Lecture 2017
  6. Teaching Scholars Program 2003-2004
  7. The UNC School of Medicine Richard H. Whitehead Lecturer 1998

Current Publications:

  1. Rivera MP, Katki H, Triplette M, Tanner NT, Carter-Harris L, Crothers K, Carderelli R, Fathi JT, Ford M, Sakoda LC, Smith R, Wiener RS, Winn R, *Henderson L, *Aldrich M. Addressing Disparities in Lung Cancer Screening Eligibility and Health Care Access: An Official ATS Policy Statement. Accepted, AJRCCM July 13, 2020
  1. Tabriz AA, Neslund-Dudas C, Turner K, Rivera MP, Reuland D, Elston Lafata How Health Care Organizations Implement Shared Decision Making. When It Is Required for Reimbursement: The Case of Lung Cancer Screening. Chest. 2020 Aug 13:S0012-3692(20)32191-7.
  1. Henderson LM, Bacchus L, Benefield T, Humani-Velasquez R, Rivera MP. An Observational Study of Lung-RADS Reporting in Academic and Community Practices in North Carolina. Trans Lung Cancer Res. 2020 Epub ahead of print
  1. Gilbert CR, Wahidi MW, Light RW, Rivera MP, et al. Management of Indwelling Tunneled Pleural Catheters: A Modified Delphi Consensus Statement. Chest 2020; June 16:S00012-2692, Epub ahead of print
  1. Pleasants RA, Rivera MP, Tilley SL, Bhatt SP. Both Duration and Pack-years of Tobacco Smoking Should be Used for Clinical Practice and Research. Ann Am Thorac Soc, 2020;17:804-806
  1. Mazzone PJ, Gould MK, Arenberg DA, Chen AC, Choi HK, Detterbeck FC, Farjah F, Fong KM, Iaccarino JM, James SM, Kanne JP, Kazerooni EA, MacMahon H, Naidich DP, Powel CA, Raoof S, Rivera MP, Tanner NT, Tanoue LK, Tremblay A, Vachani A, White CS, Wiener RS, Silvestri GA. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic. CHEST Expert Panel Report. Chest 2020;158:406-415
  1. Haddad DN, Sandler KL, Henderson LM, Rivera MP, Aldrich MC. Disparities in Lung Cancer Screening: A Review. Ann Am Thorac Soc. 2020;17:399-405
  1. Rivera MP. Passion, Perseverance and Quantum Leaps: Lung Cancer in the 21st Century. Clin Chest Med 2020;41:doi:10.1016
  1. MacRosty C, Rivera MP. Lung Cancer in Women: A Modern Epidemic. Clin Chest Med. 2020;41:53-65
  1. Silvestri GA, Bevill BT, Huang J, Brooks M, Choi Y, Kennedy G, Lofaro L, Chen A, Rivera MP, Tanner NT, Vachani A, Yarmus L, Pastis NJ. An evaluation of diagnostic yield from Bronchoscopy: the impact of clinical/radiographic factors, procedure type and degree of suspicion for cancer. Chest. 2020;157: 1656-1664
  1. Bringhurst J, Weber DJ, Miller M, Rivera MP, Akulian J, Rutala WA, Sickbert-Bennett EE. A Bronchoscopy-Associated Pseudo-Outbreak of Mycobacterium mucogenicum Traced to Use of Contaminated Ice Used for Bronchoalveolar Lavage. Infect Cont Hosp Ep 2020;41:124-126
  1. Sears CR, Tobias P, Possick JD, Camus P, Gaga M, Garon ED, Gould MK, Naidoo J, Nishino M, Patel SP, Limper AH, Montgrain P, Travis WD, *Rivera MP. Knowledge Gaps in Immune-checkpoint inhibitor-related pneumonitis: A Research Statement. Am J Resp Crit Care Med. 2019;200:e31-e43. *Co-Chair and Senior author
  1. Burks CA, Gould MK, Silvestri GA, Yarmus LB, Nana-Sinkam P, Vachani A, Fuster MM, Tanner NT, Wahidi MM, Arenberg DA, Gonzalez AV, Sears CR, Slatore CG, Tanoue LT, Rivera MP.* Safely and Effectively Evaluating CT Detected Lung Lesions: Much Work to be Done. Accepted Annals Am Thorac Soc 8/2019 * Senior author
  1. Thiboutot J, Yarmus LB, Lee HJ,Rivera MP, Ost DE, Feller-Kopman D. Real-World Application of the Navigate Trial. J Thorac Oncol. 2019 Jul;14(7):e146-e147
  1. Long J, Petrov R, Haithcock B, Chambers D, Belanger A, Burks AC, Rivera MP,Ghosh S, MacRosty C, Delgado A, Akulian Perioperative Electromagnetic Transthoracic Nodule Localization for Minimally Invasive Pulmonary Resection. Ann Thorac Surg. 2019 Jun 21. pii: S0003-4975(19)30873-2. doi: 10.1016/j.athoracsur.2019.04.107. [Epub ahead of print]
  1. Belanger A, Hollyfield J, Yacovone G, Ceppe AS, Akulian J, Burks C, Rivera MP, Dodd L, Long JM, Haithcock BE, Pecot CV. Incidence and Clinical Relevance of NSCLC Lymph Node Micro-Metastasis Detected by Staging EBUS-TBNA. J Thorac Disease 2019;doi:10.21037/jtd.2019.05.36 [Epub ahead of print]
  1. Henderson LM, Benefield TS, Bearden SC, Reuland, DS, Goldstein, AO, Throneburrg A, Rivera, MP. Changes in physician knowledge, attitudes, beliefs, and practices regarding lung cancer screening. Annals Am Thorac Soc 2019; [Epub ahead of print]
  1. Weiner RS, Rivera MP. Lung cancer screening programs in the United States: Perpetuating the inverse care law. Chest 2019; 155:883-885
  1. Rivera MP, Henderson L. Lung Cancer Screening and Shared Decision Making in Cancer Survivors: The Long and Winding Road. Trans Lung Cancer Res 2019;8(2):119-123
  1. Rivera MP. Management of Malignant Pleural Effusions: Round and round we go. Annals Am Thorac Soc 2019;16:59-61
  1. Belanger A, Burks CA, Chambers DM, Ghosh S MacRosty C, Conterato A, Rivera MP, Akulian JA. Peripheral Lung Nodule Diagnosis and Fiducial Marker Placement Using a Novel Tip-Tracked Electromagnetic Navigation Bronchoscopy System. J Bronchol Intervent Pulmonol 2019;26:41-48 [Epub ahead of print 2018]
  1. Henderson LM, Marsh KM, Benefield T, Jones LM, Reuland D, Brenner A, Goldstein A, Molina PL, Maygarden S, Rivera MP. Opinions and Practices of Lung Cancer Screening by Physician Specialty in a Large Academic Medical Center. NC Med J 2019;80:19-26
  1. Cubillos L, Brenner AT, Birchard K, Henderson L, Jones L, Molina P, Pignone MP, Ratner S, Rivera MP, Reuland DS. Multidisciplinary Quality Improvement Initiative to Standardize Reporting of Lung Cancer Screening. Transl Lung Cancer Res 2018;7 (Suppl 3): S297-S301
  1. Rivera MP, Tanner NT, Silvestri GA, et al. Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med 2018; 198:e3-e13
  1. Beattie J, Yarmus L, Wahidi M, Rivera MP, Gilbert C, Maldonado F, Czarnecka K. Argento A, Chen A, Herth F, Sterman DH. The Immune Landscape of Non-Small Cell Lung Cancer: Utility of Cytologic and Histologic Samples Obtained Through Minimally Invasive Pulmonary Procedures. Am J Respir Crit Care 2018;198: 24-38 [Epub ahead of print]
  1. Henderson LM, Jones L, Marsh KM, Brenner AT, Goldstein AO, Benefield T, Greenwood-Hickman MA, Molina P, Rivera MP, Rueland D.  Opinions, Practice Patterns, and Perceived Barriers to Lung Cancer Screening among Attending and Resident Primary Care Physicians. Risk Manag and Healthc Policy 2018;10: 189–195
  1. Brenner A, Cubillos L, Birchard K, Henderson L, Molina P, Pignone MP, Ratner S, Rivera MP, Reuland DS. Improving the implementation of lung cancer screening guidelines at an academic medical center. J Healthc Qual. 2018;40:27-35[Epub ahead of print 2017]
  1. Henderson LM, Jones LM, Marsh MW, Benefield T, Rivera MP, Molina PL. Lung Cancer Screening Practices in North Carolina CT Facilities. J Am Coll Radiol 2017; 14:166-170